KLHDC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.691400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.636800E-01
Normal-vs-Stage2
8.306800E-01
Normal-vs-Stage3
2.179000E-01
Normal-vs-Stage4
7.413600E-01
Stage1-vs-Stage2
2.491600E-01
Stage1-vs-Stage3
1.827420E-01
Stage1-vs-Stage4
6.037800E-01
Stage2-vs-Stage3
4.074600E-01
Stage2-vs-Stage4
4.375000E-01
Stage3-vs-Stage4
2.936600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.341400E-01
Normal-vs-AfricanAmerican
8.929200E-01
Normal-vs-Asian
5.008800E-01
Caucasian-vs-AfricanAmerican
8.106200E-01
Caucasian-vs-Asian
2.633800E-01
AfricanAmerican-vs-Asian
4.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.840600E-01
Normal-vs-Female
9.037800E-01
Male-vs-Female
5.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.076200E-01
Normal-vs-Age(41-60Yrs)
7.490000E-01
Normal-vs-Age(61-80Yrs)
9.478200E-01
Normal-vs-Age(81-100Yrs)
2.363600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.810400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.660400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.254200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.475810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.344300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.021800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.610200E-01
Normal-vs-Daily Drinker
8.393200E-01
Normal-vs-Weekly Drinker
7.702800E-01
Normal-vs-Occasional Drinker
6.698200E-01
Normal-vs-Social Drinker
6.599600E-01
Non Drinker-vs-Daily Drinker
1.754610E-01
Non Drinker-vs-Weekly Drinker
2.564000E-01
Non Drinker-vs-Occasional Drinker
5.911500E-02
Non Drinker-vs-Social Drinker
7.214300E-02
Daily Drinker-vs-Weekly Drinker
9.218600E-01
Daily Drinker-vs-Occasional Drinker
2.327800E-01
Daily Drinker-vs-Social Drinker
2.556000E-01
Weekly Drinker-vs-Occasional Drinker
2.165800E-01
Weekly Drinker-vs-Social Drinker
2.376600E-01
Occasional Drinker-vs-Social Drinker
9.862000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.895430E-01
Normal-vs-Grade 2
1.064180E-01
Normal-vs-Grade 3
3.324000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.690840E-01
Grade 1-vs-Grade 3
1.297990E-01
Grade 1-vs-Grade 4
1.895430E-01
Grade 2-vs-Grade 3
7.502400E-01
Grade 2-vs-Grade 4
1.064180E-01
Grade 3-vs-Grade 4
3.324000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.143600E-01
Normal-vs-NonDiabetic
9.942600E-01
Diabetic-vs-NonDiabetic
4.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.980400E-01
Normal-vs-NoPancreatitis
9.702000E-01
Pancreatitis-vs-NoPancreatitis
6.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.715600E-01
Normal-vs-N1
8.569800E-01
N0-vs-N1
2.884800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.452200E-01
Normal-vs-TP53-NonMutant
1.221250E-01
TP53-Mutant-vs-TP53-NonMutant
9.789300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
